1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: E7050-701, 2011-000752-41, NCT01271504
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: E7050-702, 2011-000773-31, NCT01332266
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: not specified Sponsor: Pharmaceutical / Industry Protocol IDs: E7050-G000-901, NCT01433991
|
|
4.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: E7050-E044-101, NCT00869895
|
|
5.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 20 to 74 Sponsor: Pharmaceutical / Industry Protocol IDs: E7050-J081-110, NCT01428141
|